kpv vs bpc-157
kpv (B-tier) vs bpc-157 (A-tier). mechanism, trials, claims vs data, dosing literature. side-by-side reference.
kpv — tier B
tiny three-amino-acid peptide for inflammation. IBD, eczema, autoimmune. none of α-MSH's tanning or appetite side effects.
a three-amino-acid fragment of alpha-MSH. preserves the anti-inflammatory tail without the tanning, appetite, or arousal effects.
picomolar NF-kB inhibition · half-life short in plasma; stable in GI tract (unusual for a peptide, supports oral delivery) · healing
bpc-157 — tier A
the contested repair peptide. strong animal data, thin human trials, huge community gravity.
the contested repair peptide. 200+ rat studies with consistent tissue-repair signals. zero published controlled human RCTs in tendon or injury recovery.
200+ rodent · 0 RCTs · half-life short (minutes IV) · healing
at a glance
reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.